These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
392 related items for PubMed ID: 3916739
1. Potential clinical utility of monoclonal antibodies in the management of human carcinomas. Schlom J, Weeks MO. Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739 [No Abstract] [Full Text] [Related]
2. [Monoclonal antibodies and cancer]. López González JS, Selman Lama M. Salud Publica Mex; 1985; 27(3):213-34. PubMed ID: 2996157 [No Abstract] [Full Text] [Related]
3. Pancreatic tumor antigens: diagnostic markers and targets for immunotherapy. Finn OJ. Important Adv Oncol; 1992; ():61-77. PubMed ID: 1374733 [No Abstract] [Full Text] [Related]
4. Basic principles and applications of monoclonal antibodies in the management of carcinomas: the Richard and Hinda Rosenthal Foundation award lecture. Schlom J. Cancer Res; 1986 Jul; 46(7):3225-38. PubMed ID: 3518915 [No Abstract] [Full Text] [Related]
5. Monoclonal antibody therapy for solid tumors. Green MC, Murray JL, Hortobagyi GN. Cancer Treat Rev; 2000 Aug; 26(4):269-86. PubMed ID: 10913382 [Abstract] [Full Text] [Related]
6. Development and evaluation of monoclonal antibody-based immunoassays: breast carcinoma-associated mucins as tumor markers. Brown JP, Linsley PS, Horn D. Immunol Ser; 1990 Aug; 53():69-82. PubMed ID: 1713071 [No Abstract] [Full Text] [Related]
7. Engineering mouse monoclonal antibodies for cancer immunotherapy. Orlandi R. Year Immunol; 1993 Aug; 7():69-73. PubMed ID: 8372514 [No Abstract] [Full Text] [Related]
14. Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody. Herlyn DM, Steplewski Z, Herlyn MF, Koprowski H. Cancer Res; 1980 Mar; 40(3):717-21. PubMed ID: 7471090 [Abstract] [Full Text] [Related]
15. Improved radioimmunotherapeutic efficacy of an anticarcinoma monoclonal antibody (131I-CC49) when given in combination with gamma-interferon. Greiner JW, Ullmann CD, Nieroda C, Qi CF, Eggensperger D, Shimada S, Steinberg SM, Schlom J. Cancer Res; 1993 Feb 01; 53(3):600-8. PubMed ID: 8425194 [Abstract] [Full Text] [Related]
16. Symposium on diagnosis and treatment of cancer. Recent progress. Jpn J Med; 1988 Feb 01; 27(1):96-112. PubMed ID: 2452911 [No Abstract] [Full Text] [Related]
17. A novel human monoclonal antibody derived from tumor-infiltrating lymphocytes in lung cancer inhibits cancer cell growth with morphological changes. Aoki M, Saikawa Y, Hosokawa S, Fukuda K, Kumai K, Kubota T, Yoshida M, Otani Y, Kitajima M. Anticancer Res; 2005 Feb 01; 25(6B):3791-8. PubMed ID: 16309165 [Abstract] [Full Text] [Related]
18. Immunotherapy for recurrent colorectal cancers with human monoclonal antibody SK-1. Koda K, Glassy MC, McKnight ME, Yasutomi J, Saito N, Dan M, Nakajima N. Anticancer Res; 2001 Feb 01; 21(1B):621-7. PubMed ID: 11299816 [Abstract] [Full Text] [Related]
19. Pre-clinical models for immunotherapy of melanoma. Reisfeld RA. Prog Clin Biol Res; 1989 Feb 01; 288():183-93. PubMed ID: 2654950 [No Abstract] [Full Text] [Related]
20. Immunotherapy and gene therapy of cancer using antibodies or their genes against tumor-associated antigens. Kuroki M, Shibaguchi H, Imakiire T, Uno K, Shirota K, Higuchi T, Shitama T, Yamada H, Hirose Y, Nagata A, Kuroki M. Anticancer Res; 2003 Feb 01; 23(6a):4377-81. PubMed ID: 14666724 [Abstract] [Full Text] [Related] Page: [Next] [New Search]